Target Name: LOC105374595
NCBI ID: G105374595
Review Report on LOC105374595 Target / Biomarker Content of Review Report on LOC105374595 Target / Biomarker
LOC105374595
Other Name(s): Uncharacterized LOC105374595 | uncharacterized LOC105374595

Un Characterized LOC105374595: A Potential Drug Target and Biomarker

LOC105374595 is a protein that is expressed in various tissues of the human body. Its function and structure have not been fully determined, but it is known to play a critical role in several cellular processes. LOC105374595 has been identified as a potential drug target and biomarker, which could be useful for the development of new therapeutic approaches for various diseases.

Potential Drug Target

LOC105374595 is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. This process is critical for the development and maintenance of tissues and organs, and is also involved in the formation of blood vessels. LOC105374595 is known to play a role in the regulation of cell-cell adhesion by interacting with several proteins, including E-cadherin.

E-cadherin is a transmembrane protein that is involved in cell-cell adhesion. It is a glycoprotein that consists of an extracellular region, a transmembrane region, and an intracellular region. E-cadherin is a critical protein for the development and maintenance of tissues and organs, as it helps to regulate cell-cell adhesion.

LOC105374595 has been shown to interact with E-cadherin, which suggests that it may play a role in the regulation of cell-cell adhesion. This interaction between LOC105374595 and E-cadherin could be a potential drug target for the development of new therapeutic approaches for diseases such as cancer, where the regulation of cell-cell adhesion is disrupted.

Biomarker

LOC105374595 may also be used as a biomarker for the diagnosis and monitoring of certain diseases. For example, LOC105374595 has been shown to be expressed in several types of cancer, including breast cancer, lung cancer, and colorectal cancer. This suggests that LOC105374595 may be a useful biomarker for the diagnosis and monitoring of these diseases.

In addition, LOC105374595 has also been shown to be involved in the regulation of cell signaling pathways, which are critical for the development and maintenance of tissues and organs. This suggests that LOC105374595 may be a useful biomarker for the diagnosis and monitoring of diseases that are caused by disruptions in these signaling pathways, such as cancer.

Conclusion

LOC105374595 is a protein that is involved in several cellular processes that are critical for the development and maintenance of tissues and organs. Its interaction with E-cadherin suggests that it may be a potential drug target for the development of new therapeutic approaches for diseases such as cancer. In addition, LOC105374595 has also been shown to be involved in the regulation of cell signaling pathways, which suggests that it may be a useful biomarker for the diagnosis and monitoring of diseases that are caused by disruptions in these signaling pathways. Further research is needed to fully determine the function and potential of LOC105374595 as a drug target and biomarker.

Protein Name: Uncharacterized LOC105374595

The "LOC105374595 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374595 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428